Lifeward Appoints 30-Year Veteran Dr. Rose as CMO to Advance ORMD-0801 Platform
LFWD•Lifeward appointed Dr. Keith D. Rose, with 30 years of rehabilitation medicine and neuroscience expertise, as Chief Medical Officer to lead its global medical strategy and enhance clinical evidence generation across its neurorehabilitation and biomedical offerings. His promotion supports expansion of Lifeward’s Protein Oral Delivery biomed platform, including lead candidate ORMD-0801 targeting the diabetes market.
1. Leadership Strengthening
Lifeward named Keith D. Rose, M.D., as Chief Medical Officer. Dr. Rose brings over 30 years of rehabilitation medicine, neuroscience and medical affairs leadership to guide global medical strategy, evidence generation and payer engagement across Lifeward’s med-tech and biopharma initiatives.
2. Portfolio and Platform Expansion
In his new role, Dr. Rose will support the expansion of Lifeward’s neurorehabilitation devices such as ReWalk Exoskeleton, AlterG Anti-Gravity and MyoCycle FES System. He will also advance the Protein Oral Delivery biomed platform, including lead candidate ORMD-0801 targeting diabetes, aligning clinical innovation with strategic growth objectives.
